Giménez-Palomo Anna, Dodd Seetal, Anmella Gerard, Carvalho Andre F, Scaini Giselli, Quevedo Joao, Pacchiarotti Isabella, Vieta Eduard, Berk Michael
Bipolar and Depressives Disorders Unit, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Mental Health Research Networking Center (CIBERSAM), Madrid, Spain.
Deakin University, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, VIC, Australia.
Front Psychiatry. 2021 Jul 6;12:546801. doi: 10.3389/fpsyt.2021.546801. eCollection 2021.
Mitochondria are cellular organelles involved in several biological processes, especially in energy production. Several studies have found a relationship between mitochondrial dysfunction and mood disorders, such as major depressive disorder and bipolar disorder. Impairments in energy production are found in these disorders together with higher levels of oxidative stress. Recently, many agents capable of enhancing antioxidant defenses or mitochondrial functioning have been studied for the treatment of mood disorders as adjuvant therapy to current pharmacological treatments. A better knowledge of mitochondrial physiology and pathophysiology might allow the identification of new therapeutic targets and the development and study of novel effective therapies to treat these specific mitochondrial impairments. This could be especially beneficial for treatment-resistant patients. In this article, we provide a focused narrative review of the currently available evidence supporting the involvement of mitochondrial dysfunction in mood disorders, the effects of current therapies on mitochondrial functions, and novel targeted therapies acting on mitochondrial pathways that might be useful for the treatment of mood disorders.
线粒体是参与多种生物过程的细胞器,尤其在能量产生过程中发挥作用。多项研究发现线粒体功能障碍与情绪障碍之间存在关联,如重度抑郁症和双相情感障碍。在这些疾病中发现了能量产生受损以及氧化应激水平升高的情况。最近,许多能够增强抗氧化防御或线粒体功能的药物已被研究用于作为当前药物治疗的辅助疗法来治疗情绪障碍。对线粒体生理学和病理生理学的更深入了解可能有助于识别新的治疗靶点,并开发和研究新的有效疗法来治疗这些特定的线粒体损伤。这对于难治性患者可能特别有益。在本文中,我们对目前支持线粒体功能障碍与情绪障碍相关的现有证据、当前疗法对线粒体功能的影响以及作用于线粒体途径可能对情绪障碍治疗有用的新型靶向疗法进行了重点叙述性综述。